MedTech Acquisition Corp. (NASDAQ:MTAC) announced in an 8-K this morning that it has added a $17.8 million convertible share investment and $2 million backstop to its pending combination with TriSalus Life Sciences.
Investors are to purchase 1,785,502 series A convertible preferred shares at $10 per share. These will provide an 8% per annum dividend, which will be payable by the combined company in a mix of cash or shares to its discretion.
All of these preferred shares will be automatically converted into common shares on the four-year anniversary of the deal’s close at a price pegged to the 10-day VWAP of the combined company’s stock.
The SPAC’s sponsor has also committed that it will together with affiliates backstop at least $2 million and up to $3 million worth of shares depending upon the extent to which they participate in the convertible share investment.
The move comes as MedTech is coming up on a June 12 special meeting to extend its transaction deadline from June 22 to September 22. The sponsor has agreed to contribute $0.04 per share monthly to its trust in connection with the move. MedTech and TriSalus also agreed last month to drop the deal’s minimum cash condition to $35 million from $60 million.
MedTech initially announced its $234 million combination with TriSalus Life Sciences in November. Denver-based TriSalus is developing a range of cancer treatments that utilize the company’s approved and commercialized medical device.
In April, TriSalus presented clinical data from its Phase I trials, which indicated positive results in reducing tumor growth in liver cancer patients.
Terms Tracker for the Week Ending September 22, 2023 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. SPACs finally saw two new S-1 filings this week, the first to file since August 24th. Hainan Sirius Acquisition Corp. filed first on Thursday and...
Latest SPAC Liquidations: LF Capital Acquisition Corp. II LF Capital Acquisition Corp. II (LFAC) to Liquidate on October 3, 2023 LF Capital Acquisition Corp. II (Nasdaq: LFAC), today announced that the directors of the Company have determined to dissolve and liquidate the Company. The redemption of the Public Shares is expected to be completed on...
Latest Non-Redemption Agreements: Yotta Acquisition Corp.,Live Oak Crestview Climate Acquisition Corp. Yotta Acquisition Corp. (YOTA) Adds Non-Redemption Agreements Yotta Acquisition Corp. (NASDAQ:YOTA) entered into non-redemption agreements with certain unaffiliated third parties in exchange for such third parties agreeing not to redeem an aggregate of 598,680 shares of the Company’s common stock. In exchange for the foregoing...
Twin Ridge (NYSE:TRCA) announced this afternoon that it plans to convene and then adjourn its extraordinary general meeting of its shareholders originally to be held on September 26 at 11:30 a.m., Eastern Time. Twin Ridge intends to hold the new meeting at 11:30 a.m., Eastern Time, on October 3, 2023. Additional details were not given as to...
Social Leverage Acquisition Corp I (Nasdaq: SLAC) and W3BCLOUD Holdings Inc. announced this afternoon that they have mutually agreed to terminate their business combination agreement. The reasons cited were once again “due to existing market conditions”, which most likely implies the current capital market conditions as well as the fact that W3BCLOUD works within the...